Abstract

Early introduction of SAARDs may be more beneficial than delayed introduction for patients with recently diagnosed rheumatoid arthritis.

Keywords

MedicineErythrocyte sedimentation rateRheumatoid arthritisAntirheumatic drugsInternal medicineArthritisRandomized controlled trialClinical trialSurgeryAntirheumatic Agents

Affiliated Institutions

Related Publications

Rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic, inflammatory, autoimmune disease that primarily affects the joints and is associated with autoantibodies that target various molecules in...

2018 Nature Reviews Disease Primers 2251 citations

Publication Info

Year
1996
Type
article
Volume
124
Issue
8
Pages
699-707
Citations
473
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

473
OpenAlex

Cite This

Agnes van der Heide, Johannes W G Jacobs, J W Bijlsma et al. (1996). The Effectiveness of Early Treatment with “Second-Line” Antirheumatic Drugs. Annals of Internal Medicine , 124 (8) , 699-707. https://doi.org/10.7326/0003-4819-124-8-199604150-00001

Identifiers

DOI
10.7326/0003-4819-124-8-199604150-00001